Manipal Health Enterprises IPO - GMP, Subscription, Price, Dates & Financial Details
Manipal Health Enterprises IPO is set to open its Initial Public Offering (IPO) for subscription on July 29, 2026. According to the Red Herring Prospectus (RHP), the IPO is a book-built issue with a total issue size of ₹9,275 Crore, comprising a fresh issue of 13.56 Crore equity shares aggregating to ₹8,000.00 Crore and an offer for sale (OFS) of 2.16 Crore equity shares aggregating to ₹1,275.22 Crore by the existing shareholders.
The Manipal Health Enterprises IPO will open for subscription on July 29, 2026, and close on July 31, 2026. The basis of allotment is expected to be finalized on August 03, 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on August 05, 2026.
The company has fixed the price band at ₹560 to ₹590 per share, with a lot size of 25 shares. Retail investors will require a minimum investment of ₹14,750 (based on the upper price band) to apply for one lot.
The IPO also includes a reservation for eligible employees, who will receive a discount of ₹56 per share.
KFin Technologies Limited is the registrar to the issue. Axis Capital Limited, Goldman Sachs (India) Securities Private Limited, J.P. Morgan India Private Limited, Jefferies India Private Limited, Kotak Mahindra Capital Company Limited, UBS Securities India Private Limited, and DBS Bank India Ltd are the Book Running Lead Managers (BRLMs) to the issue.
Before investing in the Manipal Health Enterprises IPO, investors should carefully review the company's financial performance, business model, IPO objectives, and risk factors disclosed in the offer documents. Investors should also ensure that they submit their applications before the subscription window closes on July 31, 2026.
- Price Band
- ₹ 560 – 590
- Lot Size
- 25
- Issue Size
- ₹9,275.22 Cr
- Minimum Investment
- ₹ 14,750 (25 Shares)
- Listing Date
- 05 August 2026
Current GMP
₹25 (+4.24%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Manipal Health Enterprises Limited
Manipal Health Enterprises Limited is one of India's leading healthcare service providers, operating an extensive network of multi-specialty hospitals, clinics, and diagnostic centres across the country. The company is part of the Manipal Group, founded by Dr. T. M. A. Pai, and has established a strong presence in tertiary and quaternary healthcare services.
The company provides comprehensive medical care across a wide range of specialties, including organ transplantation, oncology, cardiology, neurology, nephrology, orthopaedics, gastroenterology, critical care, and preventive healthcare. Its hospitals are equipped with advanced medical technology and supported by experienced doctors, nurses, and healthcare professionals, enabling the delivery of high-quality, patient-centric care.
Manipal Health has expanded its footprint through a combination of organic growth, strategic acquisitions, and partnerships, while continuously investing in medical infrastructure, digital health initiatives, and clinical excellence. The company serves patients across India as well as international markets, with a focus on improving healthcare accessibility and outcomes.
Hospital Network
As of September 30, 2025, Manipal Health operated:
- 38 hospitals, increasing to 48 hospitals on a pro forma basis following announced acquisitions.
- 10,761 licensed beds, expanding to 12,367 licensed beds on a pro forma basis.
- 17 clinics across India.
The company's integrated healthcare network, supported by advanced infrastructure and a broad spectrum of specialized medical services, positions it among the largest private hospital operators in India.
Manipal Health Enterprises IPO Promoters
- Dr. Ranjan Ramdas Pai
- Manipal Global Health Services
- Memg International Ltd
- Kangto Investments Pte. Ltd
- Imperius Healthcare Investments Pte. Ltd.
- Kabru Investments Pte. Ltd.
Promoters Holding
Holding Pre Issue
81.43%
Holding Post Issue
72.08%
Manipal Health Enterprises IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of our Material Subsidiaries, Manipal Hospitals Private Limited
- Acquisition of minority stake in our stepdown Subsidiary, Sahyadri Hospitals Private Limited
- General corporate purposes
Manipal Health Enterprises Limited Address / Contact Details
Manipal Health Enterprises Ltd. Address
The Annexe,
#98/2, Rustom Bagh,
HAL Airport Road,
Bengaluru, Karnataka, 560017
Telephone: +91 80 49360300
Email:legalcs@manipalhospitals.com
Website:http://www.manipalhospitals.com/
IPO Snapshot
Book Running Lead Managers
- Axis Capital Limited
- Goldman Sachs (India) Securities Private Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
- Kotak Mahindra Capital Company Limited
- UBS Securities India Private Limited
- DBS Bank India Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Manipal Health Enterprises IPO?
Manipal Health Enterprises IPO is a Book-building IPO with a total issue size of ₹9275.22 crore. The Manipal Health Enterprises IPO price band is ₹560 to 590 per share. The Manipal Health Enterprises IPO subscription opens on Wed, Jul 29, 2026, and closes on Fri, Jul 31, 2026. The Manipal Health Enterprises IPO will be listed on the BSE,NSE. KFin Technologies Limited is the registrar for the Manipal Health Enterprises IPO.
When will the Manipal Health Enterprises IPO open for subscription?
The Manipal Health Enterprises IPO opens on Wed, Jul 29, 2026 and closes on Fri, Jul 31, 2026
What is Manipal Health Enterprises IPO Price Band?
Manipal Health Enterprises IPO Price Band is ₹560 to 590 per share.
What is Manipal Health Enterprises IPO Lot Size?
Manipal Health Enterprises IPO lot size is 25 shares, Retail investors need a minimum investment of ₹14750 based on the upper price band
What is the minimum investment for Manipal Health Enterprises IPO?
The minimum investment for Manipal Health Enterprises IPO is ₹14750, based on one lot of 25 shares at the upper price band of ₹590 per share.
How to apply for Manipal Health Enterprises IPO?
Investors can apply for the Manipal Health Enterprises IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jul 31, 2026. The application amount remains blocked until the Manipal Health Enterprises IPO allotment is finalized.
What is Manipal Health Enterprises IPO Issue Size?
Manipal Health Enterprises IPO issue size is ₹9275.22 crores.
What is the Manipal Health Enterprises IPO Allotment Date?
Manipal Health Enterprises IPO allotment date is Mon, Aug 3, 2026.
Who is the Manipal Health Enterprises IPO Registrar?
The registrar for Manipal Health Enterprises IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Manipal Health Enterprises IPO allotment status, refund processing, and other IPO-related information.
What is the Manipal Health Enterprises IPO GMP?
The Manipal Health Enterprises IPO GMP (Grey Market Premium) is ₹25 as of Sun, Jul 26, 2026. Based on the upper price band of ₹590 per share, the estimated Manipal Health Enterprises IPO listing price is ₹615, indicating a potential listing gain of approximately 4.24% over the issue price.
Who is the Manipal Health Enterprises IPO Lead Manager?
The book-running lead managers (BRLMs) for the Manipal Health Enterprises IPO are Goldman Sachs (India) Securities Private Limited, J.P. Morgan India Private Limited, Jefferies India Private Limited, Kotak Mahindra Capital Company Limited, UBS Securities India Private Limited, and DBS Bank India Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Manipal Health Enterprises IPO Red Herring Prospectus (RHP).